The termination, which took immediate effect on February 13, 2025, was mutually agreed upon by bluebird bio, the original lessee Aventis Inc., and the sub-sublessee Meta Platforms (NASDAQ ...
The U.S. Food and Drug Administration has approved Sanofi-Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog ...
The termination, which took immediate effect on February 13, 2025, was mutually agreed upon by bluebird bio, the original lessee Aventis Inc., and the sub-sublessee Meta Platforms (NASDAQ:META), Inc.
Aventis’ rapid-acting insulin biosimilar product Merilog for improvement of glycaemic control in patients with diabetes: Maryland Monday, February 17, 202 ...
18h
Hosted on MSNNovel Berberine Drug Cut HbA1c in Type 2 DiabetesMore participants in the higher-dose group than placebo achieved an HbA1c under 7% (55.9% vs 15.2%) or under 6.5% (29.4% vs 6 ...
Millie, a modern maternity clinic, secured $12 million in Series A funding led by existing investors RH Capital, TMV, ...
13d
Interesting Engineering on MSNFDA approves first-ever rapid-acting insulin biosimilar for diabetes treatmentThe FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...
Stockhead on MSN14d
Dr Boreham’s Crucible: What’s all the fuss about biotech behemoth CSL?While still robust, CSL half-year results last Weds revealed impact of an “alarming” fall off in 'flu vax rates, especially ...
Two security guards stand watch outside a small castle hosting a campaign event for the far-right Alternative for Germany (AfD) in the ex-communist east, the party's heartland.
Mariposa California's original daily updated online newspaper is the premier site for news and information on Yosemite, Mariposa, California and United States ...
Hoechst and Rhône-Poulenc Rorer were the two companies that merged to form Aventis. Despite Sanofi-Synthélabo’s size, the company found itself forced to partner with larger pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results